Vivos Therapeutics (VVOS) Interest Coverage Ratio (2020 - 2026)
Vivos Therapeutics' (VVOS) quarterly Interest Coverage Ratio came in at 4.8 in Q1 2026, up 103.56% year-on-year from 2.36 in Q1 2025, and up 160.22% on a QoQ basis from 7.98 in Q4 2025.
Vivos Therapeutics (VVOS) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has 7 years of Interest Coverage Ratio data on file, last reported at 4.8 in Q1 2026.
- On a quarterly basis, Interest Coverage Ratio rose 103.56% year-over-year to 4.8 in Q1 2026; TTM through Mar 2026 was 16.41, a 104.21% increase from a year earlier, with the FY2025 full-year figure at 9.88, up 2003.06% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 4.8, up from 7.98 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for VVOS reached as high as 14.01 in Q3 2025 and fell as low as 1403.0 in Q4 2024.
- Historically, Interest Coverage Ratio has averaged 102.1 across 5 years, with a median of 7.98 in 2025.
- Across the five-year window, Interest Coverage Ratio plunged 21931.14% in 2024 and jumped 270.88% in 2025, its largest moves.
- Year by year, Interest Coverage Ratio stood at 13.91 in 2022, then jumped by 54.2% to 6.37 in 2023, then sank by 21931.14% to 1403.0 in 2024, then soared by 99.43% to 7.98 in 2025, then jumped by 160.22% to 4.8 in 2026.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 4.8 in Q1 2026, 7.98 in Q4 2025, and 14.01 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 0.90 |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 6.32 |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 13.19 |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 2.15 |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 1.19 |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 82.35 |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 5.36 |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -2.90 |
| 10 | Vivos Therapeutics | 5.92 Mn | 3.81 Mn | 3.06 Mn | 4.80 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.80 |
| Dec 31, 2025 | -7.98 |
| Sep 30, 2025 | 14.01 |
| Jun 30, 2025 | 6.71 |
| Mar 31, 2025 | -135.10 |
| Dec 31, 2024 | -1,403.00 |
| Sep 30, 2024 | -91.21 |
| Jun 30, 2024 | -3.93 |
| Mar 31, 2024 | -1.72 |
| Dec 31, 2023 | -6.37 |
| Sep 30, 2023 | -1.45 |
| Jun 30, 2023 | -1.70 |
| Mar 31, 2023 | -10.13 |
| Dec 31, 2022 | -13.91 |
| Sep 30, 2022 | -8.27 |
| Jun 30, 2022 | -10.08 |
| Mar 31, 2022 | -66.39 |
| Dec 31, 2021 | -1,852.75 |
| Sep 30, 2021 | -2.82 |
| Jun 30, 2021 | -3.55 |